Esophageal neoplasm metastatic

Known as: metastatic esophageal cancer, esophageal cancer, metastatic, Stage IV Esophageal Cancer 
Stage IV includes: For squamous cell carcinoma: Any T, Any N, M1, Any G, Tumor location: Any. For adenocarcinoma: Any T, Any N, M1, Any G. M1… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1956-2017
051019562016

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumEpithelium of esophagusEsophagus
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Esophageal neoplasm metastatic
Neoplasm Metastasis
cancer cell
Neoplastic Cell
Esophagus
Gastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Influence of sex on the survival of patients with esophageal cancer.
PURPOSE The prognostic value of sex for esophageal cancer survival is currently unclear, and growing data suggest that hormonal… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2012
2012
Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403).
BACKGROUND The aims of this multiple-institution phase II study were to evaluate the efficacy and tolerability of docetaxel… (More)
  • figure 1
  • table I
  • table III
  • table II
  • table IV
Is this relevant?
2010
2010
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).
INTRODUCTION Esophageal adenocarcinomas commonly express the epidermal growth factor receptor. This trial assessed the 6-month… (More)
Is this relevant?
2010
2010
Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.
We describe the development of an aggressive orthotopic metastatic model of esophageal cancer, which is visualized in real time… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2007
2007
Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.
BACKGROUND AND AIMS Patients with esophageal cancer often develop metastatic disease after esophageal resection and generally… (More)
Is this relevant?
2006
2006
Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner.
To metastasize, tumor cells must adopt different morphological responses to resist shear forces encountered in circulating blood… (More)
Is this relevant?
2006
2006
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm.
BACKGROUND Accurate response assessment is essential for evaluating new cancer treatments. We evaluated the impact of Response… (More)
Is this relevant?
2005
2005
Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study.
BACKGROUND We investigated the combination of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.
BACKGROUND To evaluate the activity and toxicity of docetaxel in patients with metastatic esophageal cancer. PATIENTS AND… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
Is this relevant?
2000
2000
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
PURPOSE In a phase II trial of paclitaxel, cisplatin, and fluorouracil in metastatic esophageal cancer, we identified significant… (More)
Is this relevant?